AMAT-Varian deal: What analysts are saying
If you can't beat them buy them:) AMAT has picked up the crown jewel of the ion implantation market and added Varian's Solar platform.
They paid a significant premium but, Varian's market clout and strong balance sheet complete the AMAT Dynasty.
Will ASML be the target of an acquisition? How are the most likely candidates.
This comment has been removed by the author.
ReplyDelete